MedPath

KAOPECTATE LIQ 600MG/15ML

KAOPECTATE LIQ 600MG/15ML

Discontinued
DIN Number

00836656

Drug Class

Human

Market Date

Dec 31, 1989

Company
HC

upjohn consumer products company

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number00836656
AIG Number0111623001
Classification & Schedule
C
Drug Class
Human
S
Schedule
OTC
A
ATC Code
A07BC04 ATTAPULGITE
Product Specifications
Dosage FormLiquid
Route of AdministrationOral
AHFS Classification56:08.00
Health Canada Classification

ACTIVE INGREDIENTS (1)

ATTAPULGITE (ACTIVATED)Active
Strength: 600 MG / 15 ML
Monograph: ATTAPULGITE (ACTIVATED)

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.